Cleared Traditional

K220897 - Disposable Brain Biopsy Needle 2.0

K220897 is the FDA 510(k) clearance for Disposable Brain Biopsy Needle 2.0 by PAJUNK GmbH Medizintechnologie. It is a Class 2 Neurology device (product code HAW) cleared through the Traditional 510(k) pathway after a 142-day FDA review.

K220897 · PAJUNK GmbH Medizintechnologie · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
142d
Days
Class 2
Risk

K220897 is an FDA 510(k) clearance for the Disposable Brain Biopsy Needle 2.0. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by PAJUNK GmbH Medizintechnologie (Geisingen, DE). The FDA issued a Cleared decision on August 17, 2022 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all PAJUNK GmbH Medizintechnologie devices

Submission Details

510(k) Number K220897 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2022
Decision Date August 17, 2022
Days to Decision 142 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 148d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 217
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K220897.
Stryker Q Guidance System with Cranial Guidance Software, CranialMask Tracker and Microscope Tracker, Passive Optical Navigation Instruments, Mayfield Base with Articulating Arm, and Navigated Biopsy Needle, Electromagnetic Navigation Instruments, Precision Targeting System
K212194 · Stryker Corporation · Feb 2023
ClearPoint System
K222519 · ClearPoint Neuro, Inc. · Sep 2022
Cranial EM System
K213989 · Brainlab AG · Sep 2022
Synergy Cranial v2.2.9, StealthStation Cranial v3.1.4
K221087 · Medtronic Navigation, Inc. · Jun 2022
ROSA ONE Brain application
K214065 · Medtech S.A.S · May 2022
ClearPoint Array System (version 1.1)
K214040 · ClearPoint Neuro, Inc. · Apr 2022